The third annual meeting of EndoBridge — co-hosted by the Society of Endocrinology and Metabolism of Turkey, Endocrine Society, and European Society of Endocrinology — took place in Antalya, Turkey between October 15-18, 2015.
Attracting leading endocrinology experts of the world and 440 colleagues from over 25 countries, the meeting was held in English with simultaneous translation into Russian, Arabic, and Turkish. The three-day program included 23 state-of-the-art lectures, 16 interactive case discussion sessions, and poster case presentations providing a comprehensive update across hormonal disorders.
“Endocrinology has become a large and rapidly growing field of medicine that has been instrumental in improving health and addressing pandemics of diabetes, obesity and cancer,” says Bulent Yildiz, MD, a faculty member at Hacettepe University School of Medicine in Ankara, Turkey, and the founder of EndoBridge. “The search for contemporary solutions to endocrine disorders is now global in scope. As endocrinologists from different countries and cultures, we really need to learn from each other so that we could help our patients prevent, manage, and treat their diseases and achieve better outcomes.”
Yildiz says that when he first imagined bridging the world of endocrinology 2011, he thought Turkey would be a wonderful venue since it has served as a bridge for hundreds of years between East and West, past and future, and tradition and contemporary. “After conceptualizing EndoBridge, two years of planning and preparation with collective and rigorous team effort required to bring it into reality,” he explains. “Since we first launched EndoBridge® in 2013, the initiative brought together more than 1,300 physicians and scientists with an interest in hormonal disorders from over 45 countries to share their experience and expertise, and participate in discussions with global leaders of endocrinology.”
“I am excited and pleased to see that we move forward together to continue building our bridge in the field of endocrinology while we celebrate the third annual meeting of EndoBridge,” Yildiz says. “I believe EndoBridge is a uniquely positioned and highly influential model for advancement of collaboration and a real-world impact in endocrinology across national borders.”
The fourth annual meeting of EndoBridge® will take place in Antalya, Turkey, October 20 – 23, 2016. Further information can be found at www.endobridge.org.